Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
If that's the question, they might as well revoke EU authorization for IPE to treat CVR. This is fucking ridiculous.
I'm not a lawyer, but this appears to reduce patent protection down to "don't break my heart", which excludes having an "achey-breaky heart"
Not to be confused with your privately screened "documentary": Miracle Pets
DBack caught some interesting volume on his PetCam
Brave going positive will result in multiple StatNews articles covering BP's pipelines for Alzheimers.
...look who owns Say.
srsly people we've been over this.
lizzo you of all people should know better. why would you use that app?
coincidentally, DBack was pukem's nickname in college
Because Fidelity knows better. Looks who owns Say.
Orb, quiet! Don't interrupt johnhnacoque.
Please continue to speak your truth johnhancoque. We hear you, we see you.
LOOOOOOOOOOOOOL
That was the same company that gathered a bunch of individual retail info before getting bought by Robinhood.
Shut up everyone
And that was in 2016. AI capabilities have only grown since then.
Why can't shorts be reported at level 2? There's already an order book.
Our problem is shorts generally, in a broad sense and regardless of the merits of either IPE clinical data nor consistent application of Graham.
Shorting is effectively unregulated
You really think an acquirer could negotiate AMRN down to $5 pps?
Why is AMRN dropping so hard today? Did everyone stop using the ignore button?
Classic Denner!
Ramfan just stick to blaming current CEO/BoD according to pps. Life looks simpler that way.
I must also throw my hat in the ring, and take your post without any sense of humor or sarcasm =)
oh my gawd again
the ignore button dint work
halp
(don't mind me JRoon, I'm just satirizing the safe spacers here)
oh my gawd
thank gawd for the ignore button
Most of them have muted you.
Damn, that pressures the risk premium on innovation development. If only there was a versatile property right to safeguard against that risk.
It is trending down if you rotate the chart 360 degrees.
And effectively public domain 🙃
That's not how you write a PA, ragey
It's a labor of love.
Why are so many generics pushing IPE if it's just "fish oil"?
Mr. Coque you are all anyone has to blame. It's not like the CEO is letting L0stluck talk to him (lol!)